Posted in | News | Solar Energy | Green Energy

Solar Junction Achieves Record Solar Cell Energy Efficiency on Veeco MBE System

Veeco Instruments Inc. announced today that the world record for energy efficiency of a commercial-ready production solar cell by Solar Junction was achieved on its Dual GEN200® Molecular Beam Epitaxy (MBE) System.

Solar Junction, a developer of high efficiency multi-junction solar energy cells for the concentrating photovoltaics (CPV) market, reported last October that the power conversion efficiency of their CPV cells was measured at an unprecedented 44 percent at 947 suns, as verified by the National Renewable Energy Laboratory (NREL).

Homan Yuen, Ph.D., Solar Junction’s Vice President of Research & Development, commented, “Veeco’s MBE system enables us to reach critical milestones in solar cell efficiency. Their system is instrumental in pushing the boundaries of technology to make CPV a more competitive option for solar power.”

Jim Northup, Veeco’s Vice President and General Manager, commented, “We wholeheartedly congratulate Solar Junction on their world record, and are committed to supporting their new facility’s production ramp. The GEN200 is the ideal pilot production tool, and we take great pride in providing the deposition platform for this ground-breaking result.”

The GEN200 MBE cluster-tool design provides the material source and wafer configuration flexibility for R&D or for multi-wafer production applications. The flexibility of the cluster tool design enables the GEN200 system to deliver higher throughput and lower cost per wafer, in a footprint up to 60% smaller than comparable MBE systems. It can support dual growth modules, allowing facilities to either greatly increase production or grow different materials within a single, integrated system.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.